These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2429745)

  • 1. [Clinical significance of low-level alpha-fetoprotein in the diagnosis and treatment of primary liver cancer].
    Lu PX
    Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):207-10, 254. PubMed ID: 2429745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alpha-fetoprotein variants and their significance in the differential diagnosis of primary liver cancer].
    Lu LN
    Zhonghua Yi Xue Za Zhi; 1984 Nov; 64(11):681-3. PubMed ID: 6085280
    [No Abstract]   [Full Text] [Related]  

  • 3. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
    Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
    Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary cancer of the liver in Europeans. Monocenter experience of 221 cases].
    Bertrand L; Brunin JL
    Bull Acad Natl Med; 1984; 168(5-6):642-7. PubMed ID: 6083826
    [No Abstract]   [Full Text] [Related]  

  • 5. A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 May; 7(3):397-411. PubMed ID: 6181578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
    Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
    Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
    Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
    J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase].
    Bourel M; Deugnier Y; Brissot P; Leray G; Le Gall JY
    Bull Acad Natl Med; 1987 Mar; 171(3):359-64. PubMed ID: 2444315
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early diagnosis of primary liver carcinoma].
    Weiss W; Dittrich H; Baumgartner G; Blazek G; Eder G; Hanak H; Hentschel E; Kahn P; Mastnak C; Urbanek A
    Wien Med Wochenschr; 1976 Jan; 126(1-3):16-22. PubMed ID: 56090
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up analysis of persistent low positive serum alpha-fetoprotein (AFP)--report on 420 cases].
    Zhang BC
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):26-8. PubMed ID: 2579782
    [No Abstract]   [Full Text] [Related]  

  • 14. HCC surveillance: who is the target population?
    Bruix J; Llovet JM
    Hepatology; 2003 Mar; 37(3):507-9. PubMed ID: 12601346
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic accuracy of various alpha 1 fetoprotein-determination methods in primary liver carcinoma].
    Weiss W; Eder G; Hanak H; Neumayr A
    Z Gastroenterol Verh; 1976; (11):45-8. PubMed ID: 65862
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma].
    Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
    Melia WM; Johnson PJ; Neuberger J; Zaman S; Portmann BC; Williams R
    Gastroenterology; 1984 Sep; 87(3):660-3. PubMed ID: 6204905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of transitory alpha 1 fetoprotein increases in liver cirrhosis].
    Lehmann FG
    Z Gastroenterol Verh; 1976; (11):55-61. PubMed ID: 65864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.